On 2025-11-12, Coya Therapeutics, Inc. (COYA) announced earnings per share of $-0.10 for the fiscal quarter ending 2025-09-30, missing the average analyst estimate of $0.02.
The next expected annoucement date for quarterly earnings is 2026-03-17, with an average estimated earnings per share of $-0.08 for the fiscal quarter ending 2025-12-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-11-12 | 2025-09-30 | $0.02 | $-0.10 |
| 2025-08-12 | 2025-06-30 | $-0.22 | $-0.36 |
| 2025-05-13 | 2025-03-31 | $-0.44 | $-0.44 |
| 2025-03-18 | 2024-12-31 | -- | $-0.18 |
| 2024-11-06 | 2024-09-30 | $-0.41 | $-0.26 |
| 2024-08-12 | 2024-06-30 | -- | $-0.19 |
| 2024-05-09 | 2024-03-31 | -- | $-0.35 |
| 2024-03-19 | 2023-12-31 | -- | $0.15 |
| 2023-11-08 | 2023-09-30 | -- | $-0.34 |
| 2023-08-08 | 2023-06-30 | -- | $-0.31 |
| 2023-05-10 | 2023-03-31 | -- | $-0.28 |